The National Advertising Division has referred the case of a supplement manufacturer making what have been deemed to be unsubstantiated immune health claims on to the Federal Trade Commission for possible enforcement.
Ingredient manufacturer Kyowa Hakko and parent company Kirin Holdings unveiled its novel dietary supplement ingredient Immuse to deliver what they call a new approach for broad range immune support.
A company marketing a brain health supplement has been advised by an industry watchdog to discontinue claims associated with protection against traumatic brain injuries and other health endpoints.
Nutraveris, a software firm that consults on regulatory affairs for nutrition and dietary supplement markets in Europe, has announced that they have launched an online platform for supplement compliance in the United States.
The Federal Trade Commission has issued refunds in a case brought against an herbal based pain relief supplement that the Commission alleged had insufficient backing for its claims.
Regular supplementation with either curcumin or fish oil can improve mood and memory but they do not offer synergistic benefits, according to a 16 week intervention trial.
A new paper from a prominent industry critic has found a number of unapproved drugs in a suite of cognitive and memory support products purchased online.
Dietary supplement manufacturer Pharmavite has filed a RICO lawsuit against the Clean Label Project, alleging that the organization’s testing and product grading activities amount to a protection racket.
Indian ingredient supplier Sabinsa Corp. has dialed up the pressure in its crusade about the chemical profile of amla with a legal action against fellow supplier Applied Food Sciences.
Elysium Health has launched a new brain health supplement based on research done at the University of Oxford. The supplement, called Matter, pairs a high dose suite of B vitamins with specially formulated omega-3s from fish oil.
With the support of its membership, the CoQ10 Association says it intends to test every product on the market that claims the ingredient on the label for potency and purity.
Over 70% of Americans take dietary supplements, and by now, most consumers have probably noticed the disclaimer that says "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”
Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...
The US Food and Drug Administration will not object to the use of certain qualified health claims regarding consuming certain cranberry juice and supplements and a reduced risk of recurrent urinary tract infection (UTI) in healthy women.
Consumers' interest in immune-boosting products remains at an all time high, and manufacturers are rushing to market with products to fill that need, including many botanical formulas.
The prevalence of virus-treatment claims in the marketplace has made for both heightened enforcement from federal regulators and calls for even more action from an advocacy group regarding products sold on Amazon.
The National Adverting Division has joined in the battle against coronavirus disease claims by advising a company marketing a superfoods blend to take down a video that NAD says crosses the line.
Hemp cannabidiol (CBD) supplier and manufacturer CV Sciences just announced fresh research that demonstrates the safety and health benefits of its PlusCBD products.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
The National Advertising Division has ruled that GSK must stop calling some of its Benefiber prebiotic supplements ‘100% natural.’ It’s a ruling that could be viewed as troublesome for other prebiotic ingredients.
The Federal Trade Commission has sent out another round of warning letters to 50 more marketers nationwide, most of which are labeled as dietary supplements or Chinese herbs.
Plant cell culture is an inviting technology to produce bioactives from certain botanicals. The approach is a difficult one to master, however, which is a primary reason why it is still somewhat rare in the market.
New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’
The ongoing CBD regulatory logjam has stunted the development of responsible, informative health claims for these products. I’ve speculated in these pages before that this will lead consumers to make it up as they go along. Two new studies seem to confirm...
The Federal Trade Commission just announced it is issuing refund checks totaling over $8.5 million to consumers defrauded by misleading claims on weight loss products an erectile dysfunction product in a case dating back to 2004.
The Food and Drug Administration (FDA) may have suspended all routine plant inspections, but dietary supplement producers are still expected to remain in compliance. In the meantime, the Federal Trade Commission has sent another 37 warning letters over...
The Organic Trade Association is calling on the US Department of Agriculture to help ease mounting pressure on the organic supply chain posed by the ongoing coronavirus pandemic by increasing flexibility for inspections and the disbursement of funds related...
Alkemist Labs' CEO Elan Sudberg says he's seen evidence that some ingredient suppliers and marketing companies have been altering valid lab reports and using those falsified reports to promote their products.
Supplement manufacturer NOW reports that among CoQ10 and SAMe products it purchased recently on Amazon and subjected to analytical testing, only a few came close to meeting label claim for the amount of active ingredients, while most had little or none...
The Council for Responsible Nutrition has announced that a program it had supported at the National Advertising Division will end as the major funding source has been exhausted. But both CRN and NAD said the information contained in the more than 350...
Probiotics are gaining popularity across the globe but there are various misconceptions about their role in immunity, explains Dr James Dekker, senior research scientist at Fonterra, in this Q&A with NutraIngredients.
Marketing experts recommend that brands formulate a strategy to be as nimble as possible to deal with the as yet unknown changes to the supplement marketplace in the post pandemic world. A greater online capability is seen as one of key parts of that...
Some producers of essential oils have thrown their hats into the coronavirus claims ring, according to recent warning letters from the US Food and Drug Administration and the Federal Trade Commission.
Given the current torrid pace of sales for some categories, the dietary supplement industry could emerge from the present crisis is a significantly strengthened position. Even categories that are in the doldrums stand to benefit.
On this episode, we talked with Mark LeDoux, founder, CEO and board chairman of Natural Alternatives International as well as the chairman of the Board of the Natural Products Association.
The Global Prebiotics Association has signed an influential new member—Dutch ingredients firm FrieslandCampina—which points to the growing market influence and consumer awareness of this class of ingredients, the group’s director says.
Coronavirus has given a huge portion of the population both the time and the inclination to learn more about how they can improve their health and two women devoted to gut health education have seen their virtual education platforms flipped into overdrive...
Youtheory, a brand that built its reputation on collagen, is continuing its transformation into a full line supplement brand with the launch of an immunity product based on the noted branded ingredient Wellmune.
The US Federal Trade Commission has sent 10 warning letters to network marketing companies whose participants it alleges have been making illegal COVID-19 treatment claims and earnings claims related to the pandemic crisis.
Ingredient developer ChromaDex Corp. and former customer Elysium Health have taken sharply differing views of the import of a recent appeals court decision regarding ChromaDex's patents on its nicotinamide riboside ingredient.
Norwegian supplier Nattopharma is helping to build a suite of scientific evidence on the broad cardiovascular health effects of Vitamin K2 that the company hopes will support an official recommendation on intakes of the substance.
